BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Bleomycin
,
rs6983267
,
GATA1
,
Fatty acid metabolic process
,
HIV infection
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MEKs
Summary
General Info
Curated Studies
Most Correlated Studies
Colorectal cancer cells treated with tankyrases and MEK inhibitors
Gastric cancer cells treated with MEK inhibitor PD0325901
Bone marrow stromal MS5 cells treated with MEK inhibitor (PD184352)
Melanoma cell line treated with MEK and PI3K/mTOR inhibitors
Monocytes from blood treated with TPL2 or MEK inhibitors in the presence or absence of LPS
Explore Curated Studies Results
Literature
Most Relevant Literature
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors…
The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditi…
Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats.
BILATERAL VISUAL FIELD DEFECTS IN A PATIENT TREATED WITH THE MEK AND BRAF INHIBITORS TRAMETINIB AND …
Effect of ERK1/2 Signaling Pathway Inhibitor PD98059 on the Expression of Ras, BRaf, MEK, ERK1/2 in …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
Safety, Pharmacokinetics (PK) of AKT and MEK Combination
A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumo…
MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Ac…
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treati…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ